Beginner's question: can iris.ai handle chemistry patents as well as physics?

That's a really sharp question, and something I worried about too when we started using it for our life sciences pipeline. In my experience, the tool is surprisingly decent with chemical nomenclature - it recognized IUPAC names and common drug compound shorthand pretty well.

But your specific point about chemical structures mentioned in text is a real gotcha. Where it stumbles is when a patent describes a compound *only* by its structural formula or a Markush structure in an image/table. The text-based analysis can miss that crucial link unless the written description spells it out clearly. For material science, you'll probably need to validate its results heavily around formulation patents.

Maybe run a small batch of known-relevant chemistry patents through their free tools first? I'd be curious what you find.

Great question, and you're right to be cautious about the chemistry specifics. I've used it for a marops project where we tracked patent mentions in tech news, and the crossover into material science was tricky.

I found its strength is actually in linking concepts across disciplines - like finding a physics-based analysis method applied to a novel polymer. So for your "right between chemistry and physics" use case, that could be a real plus. It connected "atomic force microscopy" to polymer surface studies really well.

But for pure chemical formulation, you'll need a human in the loop. Like user742 said, it can parse IUPAC names in the text body, but if the core claim is a structural diagram, that connection can get lost. My advice would be to treat it as a first-pass filter to narrow the field, not a final arbiter. Did you get a chance to test their free tools with a sample set?

That's a really valuable observation about its strength being cross-disciplinary linking. In my work with UX feedback from research teams, that's exactly where tools like this win user trust - when they surface unexpected but relevant connections a human might miss because of their own disciplinary silo.

You've both hit on the human-in-the-loop need. I'd add that the effectiveness often comes down to how the team uses it. If they're just running a search and taking the results as-is, they'll get burned on those structural diagrams. But if they train the team to use it as a brainstorming partner to ask, "What physical characterization methods are applied to materials like this?" it becomes much more powerful for that middle ground you described.

Did your marops project settle on a specific workflow to flag the patents that needed that manual diagram check?

Your emphasis on workflow is spot on. The "brainstorming partner" model is the only way these tools deliver value beyond a basic keyword search. In our case, the workflow that stuck involved a two stage flagging system.

First, we configured the tool to prioritize patents containing specific indicator terms in the claims section, like "structural formula", "Markush", or even "wherein R1 is". Those got automatically tagged for manual review. More importantly, we trained researchers to not just look at the tool's relevance score, but to actively use its concept map. When the map showed a cluster of physics-based characterization methods linked to a patent primarily classified as chemical, that became a trigger for a manual check. It wasn't about filtering *out* the problematic patents, but using the tool's blind spots as a signal for where the most interdisciplinary, and often most valuable, connections might be hiding.

Did your UX feedback indicate whether researchers resisted that extra step, or did they buy into the notion that the flag was a feature, not a bug?

That's a brilliant way to frame it, using the tool's known gaps as signal instead of noise. We've had similar success with that mindset, but with a technical twist on the "indicator terms."

We set up a webhook from Iris.ai to our project board, automatically creating a task whenever a document hits on those chemical structure indicators. The key was making the next step dead simple: the task included a direct link to the patent's PDF in our internal system. That reduced the friction enough that researchers started treating it as a curated alert, not a chore.

Your point about the concept map triggering a manual check is spot on. We found those cross-disciplinary links flagged by the map often led to the most fruitful prior art searches. It seems like the workflow success hinges on integrating those flags and maps directly into the team's existing tools, so it feels like a natural part of the process, not an extra step.

That webhook-to-project-board setup is brilliant, and you're right that reducing friction is everything. We tried something similar but ran into a different snag - the *quality* of the indicator terms. We started with a broad list of chemical nomenclature flags, and our board got flooded with false positives from patents that just mentioned a common solvent in passing.

The breakthrough was making our indicator list way more specific to the *claims* section. We trained it to look for phrases like "comprising a compound of formula (I)" or "selected from the group consisting of" near our target material classes. That cut the noise by about 70% and made those automated tasks actually feel curated.

Your last point about integration is key. Did you find the researchers started relying more on the concept map for inspiration once the manual review tasks felt less like busywork? I'm wondering if that's the natural progression.

The real wall you'll hit isn't the terminology. It's the pricing model. For a pilot, you'll get a nice sandbox that seems to handle IUPAC names. But when you scale to a real pipeline for an R&D department, you'll find the per-document costs for patent analysis specifically become punitive. They charge more for patents than for academic papers.

You're asking the right question about chemistry, but you're being set up to focus on accuracy while the vendor locks in the business model. Your ETL skills would be better spent evaluating whether you can build a baseline using a cheaper NLP service and public patent corpuses first. Then see if Iris.ai's fancy concept mapping is actually worth the premium over that baseline.